Shanghai Medicilon Inc (688202) — Capital Reinvestment Ratio
Shanghai Medicilon Inc (688202) has a Capital Reinvestment Ratio of 3.63x as of June 2022, meaning it reinvests 4% of its operating cash flow (CN¥9.55 Million) in capital expenditures (CN¥34.63 Million). See Shanghai Medicilon Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Medicilon Inc Capital Reinvestment Ratio (2016–2025)
This chart tracks Shanghai Medicilon Inc's Capital Reinvestment Ratio across 8 annual periods. Check how aggressively does Shanghai Medicilon Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Medicilon Inc (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Medicilon Inc from 2016 to 2025. For live market cap and broader valuation context, see Shanghai Medicilon Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥105.17 Million | CN¥69.03 Million | ▼ -92.7% |
| 2023 | 9.01x | CN¥33.32 Million | CN¥300.10 Million | ▲ +1293.7% |
| 2021 | 0.65x | CN¥452.94 Million | CN¥292.71 Million | ▲ +13.1% |
| 2020 | 0.57x | CN¥207.77 Million | CN¥118.72 Million | ▼ -65.8% |
| 2019 | 1.67x | CN¥58.30 Million | CN¥97.38 Million | ▲ +84.5% |
| 2018 | 0.91x | CN¥71.11 Million | CN¥64.37 Million | ▲ +14.8% |
| 2017 | 0.79x | CN¥74.70 Million | CN¥58.91 Million | ▼ -31.5% |
| 2016 | 1.15x | CN¥34.13 Million | CN¥39.31 Million | — |